(1r,3r,5r)-2-boc-2-azabicyclo[3.1.0]hexane-3-methylamine

Catalog No. :
ACGWNL409
CAS No. :
1638761-31-5
Molecular Formula :
C11H20N2O2
Molecular Weight :
212.29

IUPAC Name:tert-butyl (1R,3R,5R)-3-(aminomethyl)-2-azabicyclo[3.1.0]hexane-2-carboxylate

(1r,3r,5r)-2-boc-2-azabicyclo[3.1.0]hexane-3-methylamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$300.00Login to see priceInquiryInquiry
250mg98%$476.00Login to see priceInquiryInquiry
1g98%$1192.00Login to see priceInquiryInquiry
5g98%$3591.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1r,3r,5r)-2-boc-2-azabicyclo[3.1.0]hexane-3-methylamine
IUPAC Nametert-butyl (1R,3R,5R)-3-(aminomethyl)-2-azabicyclo[3.1.0]hexane-2-carboxylate
MDL No.MFCD28501263
Molecular FormulaC11H20N2O2
Molecular Weight212.29
SMILESO=C(N1[C@]2([H])C[C@]2([H])C[C@@H]1CN)OC(C)(C)C
InChI KeyZBNRVIGHEROTFW-DJLDLDEBSA-N
Synonymrel-tert-butyl (1R,3R,5R)-3-(aminomethyl)-2-azabicyclo[3.1.0]hexane-2-carboxylate;2-Azabicyclo[3.1.0]hexane-2-carboxylic acid, 3-(aminomethyl)-, 1,1-dimethylethyl ester, (1R,3R,5R)-rel-;tert-butyl rel-(1R,3R,5R)-3-(aminomethyl)-2-azabicyclo[3.1.0]hexane-2-carboxylate
CAS No.1638761-31-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACGWNL409 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGWNL409 route product structure diagram
    ACGWNL4091638761-31-5
Inquiry

2. ACGWNL409 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGWNL409 route product structure diagram
    ACGWNL4091638761-31-5
Inquiry

Comments (0)